Continuous Monitoring of Physiology and Self-reported Pain Score Amongst Post-surgical Knee Patients
ObservePAIN
Observation of In-home Continuous Monitoring of Human Physiology and Self-reported Pain Score Among Knee Replacement, Anterior Cruciate Ligament (ACL), Knee Arthroscopy & Foot & Ankle Related Surgery Patients
1 other identifier
observational
55
1 country
1
Brief Summary
The aim of this observational study is to assess whether patient reported pain levels correlate with a Pain Index derived from deviations in multivariate physiology biomarkers captured in real-world setting. This study will be conducted using a clinical-grade wearable sensor to continuously monitor patient's physiology (pain related biomarkers) and allow subject participant to actively report their pain score, symptoms and quality of life using a mobile-based application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 27, 2018
CompletedFirst Posted
Study publicly available on registry
December 28, 2018
CompletedStudy Start
First participant enrolled
February 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2020
CompletedOctober 27, 2022
October 1, 2022
1.5 years
December 27, 2018
October 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Correlation (using binary pain classification)
Agreement between patient-reported NRS pain (classified into None-Mild and Moderate-Severe) and Pain Index, measured using Kappa statistic.
30 days
Secondary Outcomes (2)
Pain Correlation in Opioid Medication Subgroup
30 days
Pain Correlation (3 pain categories)
30 days
Study Arms (1)
Monitoring arm
Monitoring subjects undergoing total knee replacement surgery using the wearable biosensor to continuously monitor physiology biomarkers.
Interventions
This study will recruit 55 patients aged 21 to 80 years who will be undergoing total knee replacement surgery. All study participants undergoing total knee replacement surgery will be monitored using the wearable biosensor to continuously monitor physiology biomarkers. Participants will be followed for an estimated total of 39 days, beginning four days before surgery, the entire period during in-patient recovery (four to five days), and 30-days post-discharge at-home.
Eligibility Criteria
55 study participants, aged between 21 to 80 years, regardless of gender, who is undergoing total knee replacement surgery will be enrolled for the study upon receiving informed consent.
You may qualify if:
- Men and women aged 21 to 80 years
- Patients undergoing knee replacement surgery ( Total Knee Replacement (TKR), Unicompartmental Knee arthroplasty (UKA), Bilateral knee replacemenent, Patello-Femoral-Joint (PFJ) Knee replacement), Anterior Cruciate Ligament(ACL), Knee Arthroscopy and Foot \& Ankle related surgery such as bunions, hammer toes, metatarsal, ankle fusion, triple fusion, ankle replacement, achilles tendon \& tibialis posterior disorder
- Ability to provide informed consent
- Able to commit to using the app and inputting data as needed during the study duration
- Has access to an iPhone (minimum requirement iPhone 5S)
You may not qualify if:
- Previous myocardial infarction (MI)
- Known coronary artery disease - prior coronary revascularization
- Previous stroke. Stroke is defined as new focal neurological deficit perspective more than 24 hours.
- More than ongoing use of 2 or more anti-hypertensive agents.
- Expected life expectancy less than 1 year.
- Asthma or chronic lung disease requiring long-term medications or oxygen
- Mental illness that in the clinical judgment of the investigator will affect participation in the study e.g. dementia
- Inability to comply with the study protocol
- Any other acute or chronic medical or physical condition deemed by the investigator to affect study outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Biofourmis Singapore Pte Ltd.lead
- Mundipharma Research Limitedcollaborator
Study Sites (1)
Singapore General Hospital (SGH)
Singapore, 169865, Singapore
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2018
First Posted
December 28, 2018
Study Start
February 2, 2019
Primary Completion
August 17, 2020
Study Completion
August 17, 2020
Last Updated
October 27, 2022
Record last verified: 2022-10